Cullinan Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 05/04/2026 | 8.96 M | $127.37 M | 0.00% | 15.14% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 7.65 M | $108.68 M | 0.00% | 12.92% |
| BVF INC/IL | 05/15/2026 | 5.75 M | $81.72 M | 0.00% | 9.71% |
| BLACKROCK, INC. | 05/13/2026 | 4.45 M | $63.23 M | 1.13% | 7.52% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 3.11 M | $44.25 M | 0.00% | 5.26% |
| STATE STREET CORP | 05/15/2026 | 2.54 M | $36.15 M | 15.78% | 4.30% |
| 05/15/2026 | 2.48 M | $35.28 M | 100.00% | 4.19% | |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 2.03 M | $28.84 M | 4,201.44% | 3.43% |
| BLUE OWL CAPITAL HOLDINGS LP | 05/14/2026 | 1.91 M | $27.14 M | -18.77% | 3.23% |
| RTW INVESTMENTS, LP | 05/15/2026 | 1.71 M | $24.24 M | 0.00% | 2.88% |
| VR ADVISER, LLC | 05/15/2026 | 1.38 M | $19.61 M | 0.00% | 2.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.37 M | $19.45 M | 5.07% | 2.31% |
| SIREN, L.L.C. | 05/14/2026 | 1.19 M | $16.96 M | 0.00% | 2.02% |
| NEXTECH INVEST, LTD. | 05/15/2026 | 1.14 M | $16.22 M | 0.00% | 1.93% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 1.11 M | $15.81 M | -10.04% | 1.88% |
| MARSHALL WACE, LLP | 05/15/2026 | 1.05 M | $14.91 M | 153.30% | 1.77% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 906.03 K | $12.87 M | 6.75% | 1.53% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 905.38 K | $12.87 M | 151.38% | 1.53% |
| NUVEEN, LLC | 04/30/2026 | 805.70 K | $11.45 M | 39.13% | 1.36% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 781.26 K | $11.10 M | -59.56% | 1.32% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 05/14/2026 | 595.49 K | $8.46 M | 0.00% | 1.01% |
| MORGAN STANLEY | 05/15/2026 | 589.48 K | $8.38 M | -23.14% | 1.00% |
| 05/08/2026 | 552.55 K | $7.85 M | 100.00% | 0.93% | |
| 05/15/2026 | 530.00 K | $7.53 M | 70.97% | 0.90% | |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 522.05 K | $7.42 M | 10.95% | 0.88% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 516.72 K | $7.34 M | 49.21% | 0.87% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 455.45 K | $6.47 M | -36.91% | 0.77% |
| NORTHERN TRUST CORP | 05/14/2026 | 449.26 K | $6.38 M | 6.55% | 0.76% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 432.89 K | $6.15 M | -0.77% | 0.73% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 410.20 K | $5.83 M | 100.00% | 0.69% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 406.79 K | $5.78 M | 100.00% | 0.69% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 386.17 K | $5.49 M | 0.00% | 0.65% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 367.91 K | $5.23 M | -37.29% | 0.62% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 360.87 K | $5.13 M | 28.20% | 0.61% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 346.58 K | $4.92 M | -4.39% | 0.59% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 342.85 K | $4.87 M | 100.00% | 0.58% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 324.11 K | $4.61 M | -48.69% | 0.55% |
| GREAT POINT PARTNERS LLC | 05/15/2026 | 300.00 K | $4.26 M | -52.68% | 0.51% |
| JPMORGAN CHASE & CO | 05/13/2026 | 297.23 K | $3.99 M | 102.12% | 0.50% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 289.12 K | $4.11 M | 18.48% | 0.49% |
| CITADEL ADVISORS LLC | 05/15/2026 | 252.78 K | $3.59 M | 129.14% | 0.43% |
| INVESCO LTD. | 05/12/2026 | 244.15 K | $3.47 M | 87.34% | 0.41% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 243.01 K | $3.45 M | -10.00% | 0.41% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 233.84 K | $3.32 M | 0.00% | 0.40% |
| PFM HEALTH SCIENCES, LP | 05/15/2026 | 227.41 K | $3.23 M | 0.18% | 0.38% |
| UBS GROUP AG | 05/05/2026 | 202.39 K | $2.88 M | -25.52% | 0.34% |
| JUMP FINANCIAL, LLC | 05/14/2026 | 193.80 K | $2.75 M | -46.89% | 0.33% |
| LONGAEVA PARTNERS L.P. | 05/15/2026 | 183.69 K | $2.61 M | 100.00% | 0.31% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 05/14/2026 | 173.74 K | $2.33 M | -49.45% | 0.29% |
| TREXQUANT INVESTMENT LP | 05/15/2026 | 168.47 K | $2.39 M | -55.84% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cullinan Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 203 institutional investors and hedge funds held shares of Cullinan Therapeutics Inc. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 8.96 M
BioImpact Capital LLC: 7.65 M
BVF INC/IL: 5.75 M
BlackRock, Inc.: 4.45 M
Kynam Capital Management, LP: 3.11 M
STATE STREET CORP: 2.54 M
110.74% of Cullinan Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 75.10 M shares in the last 24 months. This purchase volume represents approximately $1.15 B in transactions.